Mid-Term Survival in Patients with Advanced Heart Failure Receiving an Impella Device Intended as Bridge to Transplantation

被引:0
|
作者
Jang, J. [1 ]
Ruiz, J. [1 ]
Desai, S. [1 ]
Sareyyupoglu, B. [2 ]
Paghdar, S. [1 ]
Malkani, S. [1 ]
Landolfo, K. [2 ]
Patel, P. [1 ]
Nativi, J. [1 ]
Yip, D. [1 ]
Lyle, M. [1 ]
Leoni, J. [1 ]
Pham, S. [2 ]
Goswami, R. [1 ]
机构
[1] Mayo Clin, Transplant, Jacksonville, FL USA
[2] Mayo Clin, Cardiothorac Surg, Jacksonville, FL USA
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
31
引用
收藏
页码:S24 / S24
页数:1
相关论文
共 50 条
  • [41] Mid-term and long-term mortality associated with heart failure in patients hospitalized for acute coronary syndromes
    Norscini, G.
    Vagnarelli, F.
    Taglieri, N.
    Cinti, L.
    Semprini, F.
    Nanni, S.
    Bugani, G.
    Corsini, A.
    Branzi, A.
    Melandri, G.
    EUROPEAN HEART JOURNAL, 2013, 34 : 251 - 251
  • [42] Mid-Term Outcome of Cardiac Regenerative Therapy With Autologous Myoblast Cell Sheet Transplantation for Severe Heart Failure
    Domae, Keitaro
    Miyagawa, Shigeru
    Toda, Kouichi
    Yoshikawa, Yasushi
    Fukushima, Satsuki
    Saito, Shunsuke
    Saito, Atsuhiro
    Kuratani, Toru
    Ueno, Takayoshi
    Sawa, Yoshiki
    CIRCULATION, 2016, 134
  • [43] Device profile of the heartware HVAD system as a bridge-to-transplantation in patients with advanced heart failure: overview of its safety and efficacy
    Mariani, Silvia
    Hanke, Jasmin Sarah
    Li, Tong
    Merzah, Ali Saad
    Chatterjee, Anamika
    Deniz, Ezin
    Haverich, Axel
    Schmitto, Jan D.
    Dogan, Guenes
    EXPERT REVIEW OF MEDICAL DEVICES, 2019, 16 (12) : 1003 - 1015
  • [44] CLINICAL OUTCOMES AND ADVERSE EVENTS IN CONTEMPORARY PATIENTS WITH ADVANCED HEART FAILURE RECEIVING REPEATED, PLANNED LEVOSIMENDAN INFUSIONS FOR SYMPTOMS CONTROL AND AS A BRIDGE TO HEART TRANSPLANTATION
    Galeotti, G.
    Verde, A.
    Masciocco, G.
    Foti, G.
    Perna, E.
    Ammirati, E.
    Cipriani, M.
    Frigerio, M.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0G) : G28 - G29
  • [45] Donor Age for Heart Transplantation Does Not Affect Short or Mid-Term Outcomes
    Chamogeorgakis, T.
    Joseph, S.
    Hall, S.
    Saracino, G.
    Carey, S.
    Kale, P.
    Sherwood, M.
    Gonzalez-Stawinski, G.
    Lima, B.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (04): : S221 - S221
  • [46] Mid-term results with non-heart-beating donors lung transplantation
    Gomez de Antonio, D.
    Laporta, R.
    Mora, C.
    Lopez Garcia-Gallo, C.
    Moradiellos, J.
    Gamez, P.
    Cordoba, M.
    de Pablo, A.
    Ussetti, P.
    Carreno, M. C.
    Varela, A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (02): : S108 - S108
  • [47] A ventricular assist device as a bridge to recovery, decision making, or transplantation in patients with advanced cardiac failure
    Siyamek Neragi-Miandoab
    Surgery Today, 2012, 42 : 917 - 926
  • [48] A ventricular assist device as a bridge to recovery, decision making, or transplantation in patients with advanced cardiac failure
    Neragi-Miandoab, Siyamek
    SURGERY TODAY, 2012, 42 (10) : 917 - 926
  • [49] Mid-term mortality in patients without a transthoracic echocardiogram during the first acute heart failure episode
    Gorriz Magana, J. Juan
    Fraile Sanz, A.
    Perea Egido, J.
    Espinosa Pascual, M. J.
    Olsen Rodriguez, R.
    Abad Romero, R.
    Perela Alvarez, C.
    Nieto Ibanez, D.
    Mata Caballero, R.
    Hernandez Jimenez, V.
    Saavedra Falero, J.
    Alonso Martin, J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 347 - 347
  • [50] Mid-term Prognostic Implication of hospitalized COVID-19 patients with Prior Heart Failure diagnosis
    Llacer, Pau
    Manzano, Luis
    Fernandez, Cristina
    Moreno, Mari Carmen
    Nunez, Julio
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2021, 88 : 136 - 138